GEODE CAPITAL MANAGEMENT, LLC - BIOPHARMX CORP ownership

BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 19 filers reported holding BIOPHARMX CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BIOPHARMX CORP
ValueSharesWeighting
Q1 2019$59,000
-59.0%
671,686
-50.0%
0.00%
Q4 2018$144,000
+13.4%
1,343,372
+100.0%
0.00%
Q3 2018$127,000
-14.2%
671,6860.0%0.00%
Q2 2018$148,000
-4.5%
671,6860.0%0.00%
Q1 2018$155,000
+342.9%
671,686
+107.3%
0.00%
Q4 2017$35,000
-62.0%
323,9670.0%0.00%
Q3 2017$92,000
-40.6%
323,9670.0%0.00%
Q2 2017$155,000
+1837.5%
323,967
+1775.5%
0.00%
Q1 2017$8,00017,2740.00%
Other shareholders
BIOPHARMX CORP shareholders Q1 2017
NameSharesValueWeighting ↓
Vivo Capital, LLC 16,128,515$3,561,0000.46%
Virtu Financial LLC 580,070$128,0000.01%
FRG Family Wealth Advisors LLC 30,000$7,0000.00%
FRANKLIN RESOURCES INC 9,749,615$2,153,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 671,686$148,0000.00%
MILLENNIUM MANAGEMENT LLC 16,779$4,0000.00%
OPPENHEIMER & CO INC 35,000$8,0000.00%
CREDIT SUISSE AG/ 50,003$11,0000.00%
MORGAN STANLEY 100$00.00%
Invesco Ltd. 51,964$11,0000.00%
View complete list of BIOPHARMX CORP shareholders